Tecan has announced the integration of Agentic artificial intelligence (AI) capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimise operations. Agentic AI will allow laboratories to move beyond traditional monitoring and reactive troubleshooting towards proactive actions that help prevent issues before they impact performance, quality or scientific outcomes. Early access to the enhanced Introspect platform is available, with applications focused on pharmaceutical, biotechnology and clinical laboratory environments. A milestone in the collaboration announced in March 2026, this Agentic AI development demonstrates advancement of Tecan and NVIDIA’s shared vision of enabling data-driven laboratories with AI-powered platforms designed to accelerate scientific discovery and improve laboratory productivity. Agentic

AI introduces a new paradigm for laboratory operations. Rather than identifying problems after they occur, intelligent agents can continuously analyse laboratory data, workflows and system performance to uncover hidden patterns that limit throughput, constrain scalability or reduce operational efficiency.